GlassScriptPhysician profile
Richard E Waters
NPI 1154369130
$17,653.33
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,244 · 2020: $307 · 2021: $645 · 2022: $1,442 · 2023: $13K · 2024: $280.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $11K · Food and Beverage: $1,737.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $11,278.23 |
| Food and Beverage | $1,737.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $11,109.08 | 2021-2024 | Corevalve Evolut R |
| Abbott Laboratories | $3,699.03 | 2019-2024 | Mitraclip, Navitor, Cardiomems |
| Edwards Lifesciences Corporation | $1,083.27 | 2019-2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia |
| Medtronic Vascular, INC. | $532.96 | 2019-2020 | |
| Shockwave Medical, INC | $442.87 | 2021-2022 | |
| Boston Scientific Corporation | $185.88 | 2019-2020 | |
| Philips North America LLC | $179.07 | 2023 | |
| Merck Sharp & Dohme LLC | $97.49 | 2021-2023 | Verquvo |
| Scpharmaceuticals INC. | $93.51 | 2023 | |
| E.R. Squibb & Sons, L.L.C. | $59.83 | 2019-2022 | |
| Pfizer INC. | $57.78 | 2021-2022 | |
| Siemens Medical Solutions USA, INC. | $49.54 | 2023 | |
| Astellas Pharma US INC | $29.61 | 2019-2020 | |
| Impulse Dynamics (USA) INC. | $16.82 | 2022 | |
| Sanofi-Aventis U.S. LLC | $16.59 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Waters listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.